Das Devika, Christie Hannah E, Hegazi Moustafa, Takawy Marina, Pone Karina A, Vella Adrian, Egan Aoife M
Department of Internal Medicine, Mayo Clinic, Rochester, MN 55905, USA.
Department of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic, Rochester, MN 55905, USA.
J Endocr Soc. 2024 Apr 16;8(6):bvae075. doi: 10.1210/jendso/bvae075. eCollection 2024 Apr 6.
The risk of gestational diabetes mellitus (GDM) in twin pregnancies is more than double that of singleton pregnancies. Although twin pregnancies present unique challenges for fetal growth and prenatal management, the approach to GDM diagnosis and treatment is the same regardless of plurality. Data on pregnancy outcomes for individuals with GDM and a twin pregnancy are limited and conflicting.
To describe the maternal characteristics associated with GDM in twin pregnancies and to assess the associated pregnancy outcomes compared to twin pregnancies unaffected by GDM.
A retrospective cohort study was conducted at Mayo Clinic, Rochester, Minnesota, USA, and included predominantly Causasian women aged 18 to 45 years who received prenatal care for a twin pregnancy from 2017-2022. Maternal characteristics and a broad spectrum of pregnancy outcomes were evaluated. Universal GDM screening involved a 50 g oral glucose challenge test +/- a 100 g oral glucose tolerance test.
GDM was diagnosed in 23% pregnancies (n = 104/452). Compared to those without, women with GDM had known risk factors including a higher prepregnancy body mass index (31.1vs 26.3 kg/m; < .01) and a prior history of GDM (21.7 vs 5.9%; < .01). There were no differences in maternal pregnancy complications or neonatal outcomes between groups. Attendance at postpartum glucose testing among women with GDM was poor at 27.9% (29/104).
These data suggest that women with twin pregnancies share a similar GDM risk profile to those with singleton pregnancies and provide reassuring evidence that current management for GDM twin pregnancies produces similar outcomes to twin pregnancies without GDM.
双胎妊娠中妊娠期糖尿病(GDM)的风险是单胎妊娠的两倍多。尽管双胎妊娠给胎儿生长和产前管理带来了独特的挑战,但无论妊娠次数多少,GDM的诊断和治疗方法都是相同的。关于GDM合并双胎妊娠的妊娠结局的数据有限且相互矛盾。
描述双胎妊娠中与GDM相关的母体特征,并评估与未受GDM影响的双胎妊娠相比的相关妊娠结局。
在美国明尼苏达州罗切斯特市的梅奥诊所进行了一项回顾性队列研究,主要纳入了2017年至2022年期间接受双胎妊娠产前护理的18至45岁的白人女性。评估了母体特征和广泛的妊娠结局。通用的GDM筛查包括50克口服葡萄糖耐量试验+/-100克口服葡萄糖耐量试验。
23%的妊娠(n = 104/452)被诊断为GDM。与未患GDM的女性相比,患GDM的女性有已知的风险因素,包括更高的孕前体重指数(31.1对26.3 kg/m²;P <.01)和既往GDM病史(21.7%对5.9%;P <.01)。两组之间的母体妊娠并发症或新生儿结局没有差异。GDM女性产后血糖检测的参与率很低,为27.9%(29/104)。
这些数据表明,双胎妊娠女性的GDM风险特征与单胎妊娠女性相似,并提供了令人放心的证据,即目前对GDM双胎妊娠的管理产生的结局与非GDM双胎妊娠相似。